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ABSTRACT 26 
There is a large generation of meat by-products, not only from slaughtering but also in 27 
the meat industry from trimming and deboning during further processing. This results in 28 
extraordinary volumes of by-products that are primarily used as feeds with low returns 29 
or, more recently, to biodiesel generation. The aim of this work was to review the state 30 
of the art to generate bioactive peptides from meat industry by-products giving them an 31 
added value. Hydrolysis with commercial proteases constitute the typical process and a 32 
variety of peptides result from such extensive proteolysis. This review focuses on the 33 
identification of a large number of peptides derived from the enzymatic hydrolysis of 34 
specific meat by-products and its characterisation for bioactivity.  The potential of some 35 
of the identified peptides to be used as bioactive supplements in foods has also been 36 
considered. 37 
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INTRODUCTION 46 
Meat industry annually produces tons of by-products that represent a cost for the meat 47 
processing sector as well as an important environmental problem. The generation of by-48 
products depends on tradition, culture, and religion of the production countries, but 49 
usually includes trimming, bones, blood, and skin (Nollet & Toldrá, 2011). Nowadays, 50 
industries are making a strong effort converting by-products and wastes into useful 51 
sources of both, edible and non-edible products, producing  valuable new products and 52 
functional ingredients with a significant added-value and/or a strong economic potential 53 
(Zhang, Xiao, Samaraweera, Lee & Ahn, 2010; Toldrá, Aristoy, Mora and Toldrá, 54 
2012). Fertilizers as well as biodiesel generation, pharmaceutics, and plastic or energy, 55 
would be the main non-edible use of by-products (Pearl, 2004; Ockerman and Basu, 56 
2004a,b). However, due to its strong technologic and economic potential, the 57 
development and application of edible uses for meat by-products is a current concern in 58 
the research community. In this sense, one of the most studied and promising lines is the 59 
production of protein hydrolysates, that may be used as flavor enhancers, emulsifiers, 60 
enhancers of water bonding capacity or nutrients to be added to foods since they 61 
constitute an excellent source of nutrients like essential amino acids, minerals and 62 
vitamins (Aristoy and Toldrá, 2011, Honikel, 2011, Kim, 2011; García-Llatas, Alegría, 63 
Barberá and Farré, 2011), and functional ingredients like bioactive peptides (Toldrá & 64 
Reig, 2011; Zhang, Xiao, Samaraweera, Lee, & Ahn, 2010).  65 
Science and innovation is helping the meat industry to add value to its meat by-products 66 
reducing the environmental damage but most important, converting them into products 67 
capable of covering all the processing and disposal costs (Toldrá, Mora & Reig, 2012). 68 
A diagram showing the main routes for generation of bioactives from meat by-products 69 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
4 
 
is shown in Figure 1. This manuscript reviews the latest innovations to generate 70 
bioactive peptides from meat by-products giving them a high added value. 71 
 72 
BY-PRODUCTS TREATMENT THROUGH ENZYMATIC HYDROLYSIS FOR 73 
PEPTIDES GENERATION 74 
 75 
Meat by-products wastes (trimmings and mechanically recovered meat, collagen, blood) 76 
are, in general, very rich in proteins and thus, they constitute a good substrate for 77 
proteolysis. These proteins are subject to hydrolysis with specific commercial proteases 78 
like papain, bromelain, thermolysine, pronase or proteinase K (Vercruysse, Van Camp 79 
& Smagghe, 2005). Other commercial enzymes are Neutrase
®
, a metallo-protease from 80 
Bacillus amyloliquefaciens (4 hours at pH 7.0, 50ºC), Alcalase
®
 , a serine-protease from 81 
Bacillus licheniformis  (4 hours at pH 8.0, 50ºC) or crude enzyme extract from R. 82 
Clavata (4 hours at pH 8.0, 40°C). The hydrolysis reaction is usually carried out either 83 
in batch-fed reactors or in continuous reactors using ultrafiltration membrane. Once the 84 
desired degree of hydrolysis is reached, the product is then submitted to fractionation 85 
and partial purification through filtration and/or chromatographic techniques (Arihara, 86 
2006). A typical industrial production is schematised in Figure 2. As the enzymatic 87 
hydrolysis is usually intense, a large number of peptides are generated.  88 
Endogenous proteolytic activity may also contribute to the generation of peptides and 89 
free amino acids through proteolysis mechanisms (Toldrá, 2006). Meat by-products 90 
contain endogenous muscle enzymes like calpains and cathepsins that break proteins 91 
internally followed by the action of peptidylpeptidases that generate small peptides from 92 
the amino and carboxy termini (Arihara, 2006a; Sentandreu & Toldrá, 2007; Mora, 93 
Sentandreu, Koistinen, Fraser, Toldrá & Bramley, 2009).  94 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
5 
 
Some of the generated peptides are denominated bioactive peptides because they may 95 
be able to exert a determined health benefit to the consumer like antihypertensive 96 
activity (Arihara & Ohata, 2010). 97 
 98 
TYPES OF BIOACTIVITY IN THE GENERATED PEPTIDES 99 
 100 
Bioactive peptides usually contain between 3–20 amino acid residues and their 101 
bioactivities are based on their amino acid composition and location within the 102 
sequence of amino acids that form the peptide (Pihlanto-Leppala, 2001). They are 103 
inactive in the sequences of their parent proteins, but may be released through 104 
enzymatic hydrolysis (Kim et al., 1999; Lahl and Braun, 1994), by proteolytic enzymes 105 
during gastrointestinal digestion (Escudero et al 2010), during fermentations with 106 
generally recognised as safe (GRAS) bacteria such as Lactobacilli (Philanto et al., 2001) 107 
or during food processing (Arihara and Ohata, 2010). In order to exert a positive health 108 
effect, bioactive peptides must survive enzyme degradation in the gastrointestinal tract 109 
following consumption. Once liberated in the human body, bioactive peptides can affect 110 
numerous physiological functions. Depending on their amino acid sequence, they may 111 
be involved in biological functions including prevention of hypertension (ACE-I-112 
inhibitory and antihypertensive peptides), opioid agonists or antagonists, 113 
immunomodulatory, antithrombotic, antioxidant, anti-cancer, or antimicrobial activities.  114 
Bioactive peptides are able to inhibit the angiotensin I-converting enzyme (ACE), an 115 
enzyme that participates in the renin-angiotensin system where angiotensin I is 116 
converted into antiotensin II that constricts the arteries and, as a consequence, increases 117 
the blood pressure. So, the inhibition of ACE constitutes an efficient way to reduce 118 
blood pressure (Ahmed & Mugurama, 2010). This inhibitory activity can be measured 119 
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in vitro and in vivo but its effects may not be similar because bioactive peptides must 120 
reach the cardiovascular system in an intact form. This is not always achieved because 121 
the proteases in the human gastrointestinal tract might hydrolyse some peptides and 122 
reduce them to smaller inactive peptides. Another  drawback to exert its effect is the 123 
difficulty found in its absortion through the intestinal wall into the blood. In general, the 124 
bioactivity intensity is usually inversely correlated to the peptide length (Vermeissen, 125 
Van Camp & Verstraete, 2004). Therefore, it is necessary that peptides can inhibit ACE 126 
in vitro but also exert antihypertensive effect in vivo because then they can be object of 127 
the development of novel functional foods for preventing hypertension.   128 
Other activities of interest are the antioxidant activity, antimicrobial or opioid activity 129 
among others. The antioxidant peptides can be detected through their DPPH radical-130 
scavenging activity and reducing power. It is important  because such antioxidant 131 
activity may reduce the reactive oxygen species (ROS) and other free radicals present in 132 
the food that might produce oxidative damage to DNA, proteins, and other 133 
macromolecules such as lipids (Escudero, Mora, Fraser, Aristoy and Toldrá, 2013). The 134 
opioid peptides received such name because they have an affinity for an opioid receptor 135 
that may exert an effect on the nerve system (Guesdon, Pichon & Tomé, 2005).  The 136 
antimicrobial peptides are able to inhibit the growth of certain pathogen bacteria (Chan 137 
& Li-Chan, 2005).     138 
 139 
PEPTIDES GENERATION FROM SPECIFIC BY-PRODUCTS IN THE MEAT 140 
INDUSTRY 141 
 142 
Trimmings and cuttings 143 
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Trimmings are portions of meat remaining after the preparation of primal cuts from the 144 
carcass and include fat, gristles, and meat. They can also include mechanically 145 
recovered meat. Portions of the head meat, internal organs, major tendons, or ligaments, 146 
are not considered as trimmings. They are mainly obtained by removing the last traces 147 
of skeletal muscle meat from animal bones once the primal cuts that have been carved 148 
off manually in the deboning process.  149 
Despite the meat industry make a take care of trimmings and cuttings transforming them 150 
into secondary quality meat products such as hot dogs, these by-products are as good 151 
source for bioactive peptides as the primal cuts. In fact, a wide number of studies based 152 
on the bioactive peptides generation resulting from meat protein hydrolysis have been 153 
described. Antihypertensive activity is by far the most studied biological activity 154 
although antioxidant or antimicrobial peptides derived from muscular proteins have also 155 
been described. A wide variety of enzymes have been tested in these studies. As an 156 
example, porcine skeletal muscle proteins were hydrolysed by using eight proteases and 157 
ACE-inhibitory activity measured (Arihara et al., 2001). Among the digests, 158 
thermolysin showed the best inhibitory activity, and peptides MNPPK and ITTNP were 159 
isolated and identified as ACE-inhibitors with IC50 of 945.5 and 549 M, respectively. 160 
These peptides were tested in spontaneously hypertensive rats administering single oral 161 
doses, proving their in vivo antihypertensive activity (Nakashima et al., 2002). Another 162 
peptide RMLGQTPTK (44–52 position of troponin C) was purified from porcine 163 
skeletal troponin hydrolysed with pepsin and showed ACE-inhibitory activity Katayama 164 
et al (2003). It showed an IC50 of 34 M. Same authors digested myosin light chain 165 
extracted from Japanase domestic pork loin with pepsin enzyme, and measured the 166 
ACE-inhibitory activity of the digest. This study resulted on the isolation and 167 
identification of the octapeptide VKKVLGNP, with an IC50 of 28.5 M (Katayama et 168 
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al., 2007). On the other hand, antioxidant and free radical scavenging activities were 169 
tested in a papain hydrolysate of pork myofibrillar proteins (Saiga et al., 2003). From 170 
the isolated and identified peptides, DAQEKLE sequence showed the highest 171 
antioxidant activity. In another study, peptides DLYA, SLYA, and VW were tested in 172 
vitro and in vivo for their antioxidant activity showing anti-fatigue effect in 173 
spontaneously hypertensive rats (Arihara et al 2006). 174 
The industry of meat products is also an important producer of trimmings that would be 175 
an interesting source of ACE-inhibitory and antioxidant peptides as indicated through 176 
the studies carried out on dry-cured ham during the last decade.  In this sense, 177 
antihypertensive and antioxidant activities have been described in peptide fractions 178 
extracted from Spanish dry-cured ham (Escudero et al., 2012). In this study, fractions 179 
were tested for their antihypertensive activity in vitro and in vivo by measuring changes 180 
in systolic blood pressure (SBP) of spontaneously hypertensive rats as shown in Figure 181 
3, obtaining a decrease of 38.38 mmHg in one of the analysed fractions. Recent studies 182 
focused on the purification and identification of specific peptide sequences extracted 183 
from dry-cured ham pointed the potential of this product as a source of antihypertensive 184 
and antioxidant peptides (Escudero et al., 2013b; Escudero, Mora, Fraser, Aristoy, & 185 
Toldrá, 2013a). 186 
The in vitro simulation of pork meat proteins digestion with gastrointestinal enzymes 187 
such as pepsin, chymotrypsin, and pancreatin, as well as the in vivo test of the identified 188 
peptides, is necessary to know more data about their stability against digestive proteases 189 
as well as their absorption through the intestinal wall. In this respect, the stability of 190 
ACE-inhibitory activity of dry-cured ham peptides during processing and after in vitro 191 
digestion has been recently investigated (Escudero et al., 2014). Results indicate that 192 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
peptides preserve almost the same ACE inhibitory activity before and after applying 193 
diverse heating and time conditions, as well as simulated in vitro digestion with 194 
gastrointestinal proteases. 195 
 196 
Bones (Horn) 197 
Bones, horns, and hooves resulting from meat industry are mainly used as feed material, 198 
organic fertilisers, or soil. Very few studies have described the purification and 199 
identification of bioactive peptides from these by-products. In this respect, the 200 
antioxidant peptides QYDQGV, YEDCTDCGN, and AADNANELFPPN, have been 201 
identified from an aqueous extract of water buffalo horn, commonly used in Chinese 202 
medicine. Results showed that these peptides could reduce the DPPH radical and protect 203 
rat cerebral microvascular endothelial cells against H2O2-induced injury (Liu et al., 204 
2010).  205 
However, in the sector of marine by-products, backbones hydrolysed using different 206 
enzymes have been widely studied as a source of bioactive peptides, promoting human 207 
health and preventing chronic disease (Šližytė et al, 2009; Ravallec et al, 2001; and Kim 208 
et al., 2000). As an example, the antioxidant peptide VKAGFAWTANQQLS was 209 
purified and identified in a study where tuna backbone was hydrolysed using various 210 
proteases such as alcalase, a-chymotrypsin, neutrase, papain, pepsin, and trypsin (Je et 211 
al., 2007).  212 
Bones constitute one of the most important sources to obtain collagen and gelatin, 213 
which have been described as proteins containing biologically active peptides on their 214 
sequences, with promising health benefits for humans. 215 
 216 
 217 
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Collagen 218 
Collagen is the most abundant protein in vertebrates as it is the main fibrous protein 219 
constituent in bones, cartilages, and skin (Gómez-Guillén et al., 2011). Collagen is one 220 
of the most useful proteins used in pharmaceutical companies as it has been proved that 221 
orally administered collagen peptides have beneficial effects on bone metabolism. 222 
Regarding this, ingested collagen hydrolysates obtained from chicken legs have been 223 
described to improve bone mineral density in rat finding that exerts a beneficial effect 224 
on osteoporosis by increasing the organic substance content of bone (Watanabe-225 
Kamiyana et al., 2010). On the other hand, chicken bone collagen hydrolysates 226 
treatment might help to prevent atherosclerosis through their lipid-lowering effects as 227 
well as inhibiting expression of inflammatory cytokines (Zhang et al., 2010).  228 
Despite the nutritional value of collagen is very low because it is specially rich in non-229 
essential amino acids (Gly, Pro, and Hyp), it results a very important protein in food 230 
industry as a source of bioactive peptides. During the last years, many studies have been 231 
focused on the bioactive properties of collagen enzymatic hydrolysis prepared using 232 
different by-product sources and different enzymes. Typically, collagen hydrolysate 233 
peptides were produced from pig or bovine by-products, however, due to the incidence 234 
of mad cow disease, an increase in results coming from marine processing waste 235 
sources such as skin collagen has occurred (Alemán et al., 2013).  236 
Most of the studies about collagen peptides that are focused on their bioactive properties 237 
have dealt in their antioxidant and ACE-inhibitory activity. Thus, four antioxidant 238 
peptides were identified from hydrolysed porcine skin collagen obtained using different 239 
protease treatments. One of the antioxidative peptides, Gln-Gly-Ala-Arg, was 240 
synthesized and the antioxidant confirmed in vitro (Li et al., 2007). On the other hand, 241 
four peptides showing good in vitro and in vivo ACE- inhibitory activity against 242 
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spontaneous hypertensive rats were reported from chicken skin collagen hydrolysate 243 
obtained by treatment with an Aspergillus species derived enzyme (Saiga, et al, 2008). 244 
More recently, two ACE-I inhibitory peptides with sequences 245 
AKGANGAPGIAGAPGFPGARGPSGPQGPSGPP and 246 
PAGNPGADGQPGAKGANGAP, have been identified from bovine Achilles tendon 247 
collagen. Bacterial collagenase was used to hydrolyze the collagen and it was described 248 
that peptides retained 80% of ACE-I inhibitory activity after in vitro simulation of 249 
gastrointestinal tract (Banerjee & Shanti, 2012). 250 
 251 
Blood 252 
Blood is a body fluid that constitutes a rich protein by-product. It is composed of blood 253 
cells suspended in blood plasma, being the cellular elements red blood cells (also called 254 
erythrocytes) and white blood cells, including leukocytes and platelets. Plasma contains 255 
proteins such as fibrinogen, globulins and albumins (Bah et al., 2013). Albumin is the 256 
main protein in plasma, and is a key element in the regulation of fluid distribution, 257 
colloidal osmotic pressure and the transport of small metabolites in blood (Rondeau & 258 
Bourdon, 2011). Red blood cells are the most abundant cells in vertebrate blood and 259 
contain hemoglobin, an iron-containing protein. This protein facilitates the reversibly 260 
binding of oxygen increasing its solubility and transportation in blood. 261 
Blood represents up to 4% of animal weight and could become a problematic by-262 
product in meat industry due to the tons of blood generated and its high pollutant 263 
characteristics for the environment. The interest in searching new blood uses exists 264 
since the beginning of slaughterhouses. In fact, its high content in proteins makes blood 265 
useful in food industry to increase the final nutritional value of some foods, enhance 266 
water binding, and because of its emulsifying capacity (Ofori and Hsieh, 2011). 267 
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 268 
Blood is mostly obtained from bovine and porcine sources and studies related with its 269 
value as generator of bioactive peptides used to be focused on the cellular fraction, 270 
specially hemoglobin cells, and the plasma fraction. 271 
Hemoglobin and plasma hydrolysates have been described to mainly exert 272 
antihypertensive, antioxidant, antimicrobial, and opioid activity. Some peptidic 273 
sequences showing these activities have been isolated and characterized using modern 274 
proteomic techniques. In this sense, peptides GFPTTKTYFPHF and VVYPWT, 275 
corresponding to the 34–46 fragment of the -chain and the 34–39 fragment of the 276 
chain of porcine hemoglobin, and obtained from a hydrolysate with pepsin enzyme, 277 
resulted to be ACE-inhibitory peptides, showing IC50 values of 4.92 and 6.02 M, 278 
respectively (Yu et al., 2006). Antimicrobial activity of peptides derived from 279 
hemoglobin chain is, by far, the most studied. Peptides 280 
TKAVEHLDDLPGALSELSDLHAHKLRVDPVNFKLLSHSLL, 281 
LDDLPGALSELSDLHAHKLRVDPVNFKLLSHSL, KLLSHSL, and LLSHSL, 282 
obtained from the hydrolysis of bovine-chain hemoglobin with pepsin, presented 283 
antibacterial activity against Kocuria luteus, Listeria innocua, Escherichia coli, and 284 
Staphylococcus aureus, as well as showed ACE inhibitory activity in an IC50 range from 285 
42.55 to 1,095 M (Adje et al, 2011). Catiau et al. (2011a) studied the minimal peptide 286 
sequence necessary to show antimicrobial activity when a digestion of bovine-chain 287 
hemoglobin with pepsin was done. Results showed that KYR, which was studied 288 
against five bacterial strains including Escherichia coli and Salmonella enteritidis as 289 
Gram-negative bacteria and Listeria innocua, Micrococcus luteus and Staphylococcus 290 
aureus as Gram-positive bacteria, was contained in all active peptides showing 291 
antimicrobial activity. Same authors did a similar work but studying bovine-chain 292 
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hemoglobin and concluded with the sequence RYH as the minimal antimicrobial 293 
sequence of this protein (Catiau et al., 2011b). In previous studies, Daoud et al. (2005) 294 
isolated and purified an antimicrobial peptide with sequence 295 
VTLASHLPSDFTPAVHASLDKFLANVSTVL from -chain bovine hemoglobin by 296 
hydrolysis with pepsin. The peptide displayed antimicrobial activity against M. luteus 297 
A270, Listeria innocua, Enterococcus faecalis, Bacillus cereus, Staphylococcus 298 
saprophyticus and Staphylococcus simulans. In fact, a MIC of 38 M was reported 299 
against L. innocua and 76 M for the other bacterial species (Daoud et al., 2005). 300 
Nedjar-Arroume et al. (2006) identified three peptides corresponding to positions 107–301 
141, 137–141, and 133–141 fragments of -chain bovine hemoglobin, and 126–145 302 
from -chain, all of them showing antibacterial activity against Micrococcus luteus 303 
A270, Listeria innocua, Escherichia coli, and Salmonella enteritidis (Nedjar-Arroume 304 
et al., 2006). Same authors identified in another study with pepsin enzyme a total of 305 
thirty antibacterial peptides, and twenty-four and six of them derived from - and -306 
chains of hemoglobin, respectively (Nedjar-Arroume et al., 2008). More recently, Hu et 307 
al. (2011) identified a novel antimicrobial peptide derived from α-chain bovine 308 
hemoglobin sequenced as VNFKLLSHSLLVTLASHL. The peptide showed 309 
antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida 310 
albicans when assessed using the radial-diffusion plate assay (Hu et al., 2011). 311 
Many of the studies related to opioid peptides from meat-derived sources are based on 312 
blood hydrolysates. In fact, originally, hemorphins were isolated from enzymatically 313 
treated bovine blood. Brantl et al. (1986) isolated and determined the sequence of an 314 
opioid active tetrapeptide (YPWT) from bovine blood hydrolysed with gastrointestinal 315 
enzymes. During the past decades, a number of opioid active peptides containing this 316 
sequence have been reported such as LVVYPWT, LVVYPWTQR, and 317 
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LVVYPWTQRF, which were found to be relatively stable and are believed to interact 318 
with opioid receptors in the brain and cardiovascular system (Nyberg, Carlsson, & 319 
Hallberg, 2013; Collinder, Nyberg, Sanderson-Nydahl, Gottlieb-Vedi, & Lindholm, 320 
2005).  321 
Some studies about the antioxidant properties of porcine plasma protein hydrolysate 322 
have been published during the last decade, but no sequences of the responsible 323 
peptides have been described (Liu et al., 2009 and 2010; Xu et al., 2009; and Wang et 324 
al., 2008). 325 
 326 
FUTURE TRENDS 327 
There is a large variety of applications of meat by-products. Traditional applications are 328 
primarily human and animal foods. Other applications consist of rendered fat for 329 
cosmetics and chemicals and hides for leather. More recent innovations are related to 330 
the use of proteins taking profit of its technological properties or for improved 331 
nutritional properties, and the hydrolysis of proteins for the generation of peptides with 332 
biological activity. So, it is still necessary to analyze by-products for nutritional 333 
properties, in order to search for key active molecules in food and nutrition. This is 334 
basic when considering innovative value-addition for such meat by-products. 335 
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 Legends for the figures 669 
 670 
Figure 1.- Flow diagram of main routes for value-addition to meat by-products  671 
 672 
Figure 2.- Flow diagram for the generation of bioactive peptides through the enzymatic 673 
hydrolysis of edible meat by-products. 674 
 675 
Figure 3. - Fractionation of dry-cured ham extract on a Sephadex G-25 gel filtration 676 
column. Fractions were collected and assayed for in vitro ACE-inhibitory activity. For 677 
antihypertensive in vivo assay in the present study, fractions corresponding to an elution 678 
volume from 200 mL to 320 mL were pooled and named sample 1 (S1). The same 679 
procedure was followed for fractions corresponding to elution volumes from 325 mL to 680 
450 mL (S2) and those from 505 mL to 625 mL (S3). Reprinted from Escudero et al 681 
Meat Science, 2012, 91. 306-311 with permission from Elsevier.  682 
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